Title : Cost effectiveness of dipeptidyl peptidase-4 inhibitors for type 2 diabetes.

Pub. Date : 2015 Jun

PMID : 25736235






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Of the seven studies comparing DPP-4 inhibitors plus metformin with sulfonylureas plus metformin, six concluded that DPP-4 inhibitors were cost effective in patients with type 2 diabetes who were no longer adequately controlled by metformin monotherapy. Metformin dipeptidyl peptidase 4 Homo sapiens
2 Of the seven studies comparing DPP-4 inhibitors plus metformin with sulfonylureas plus metformin, six concluded that DPP-4 inhibitors were cost effective in patients with type 2 diabetes who were no longer adequately controlled by metformin monotherapy. Metformin dipeptidyl peptidase 4 Homo sapiens
3 Of the seven studies comparing DPP-4 inhibitors plus metformin with sulfonylureas plus metformin, six concluded that DPP-4 inhibitors were cost effective in patients with type 2 diabetes who were no longer adequately controlled by metformin monotherapy. Metformin dipeptidyl peptidase 4 Homo sapiens